fda approval status bpc-157 This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make BPC-157 FDA Approval Status: Is

Usage: Target Species: Horses, cattle, dogs, and cats Indications: Treatment and prevention of anemia due to Vitamin B12 deficiency Administration: Dosage: Horses and Cattle: 14 mL administered subcutaneously (S.C.), intramuscularly (I.M.), or intravenously (I.V.) Dogs and Cats: 0.51 mL administered S.C., I.M., or I.V

A randomised controlled trial published in Clinical Infectious Diseases demonstrated that Thymosin Alpha-1 treatment in severe COVID-19 patients reduced 28-day mortality by 30% compared to standard care alone.17 While this was acute disease, not long COVID, it confirms the biological plausibility of the immune mechanism

suggested that the results of an ideal repair or reconstruction of the scapholunate ligament should include

Acne involves comedones, pustules, and cysts with a different distribution pattern and different triggers

Oral BPC-157 is used primarily for gut health applications

Not sure what I get in the injections Not really seeing any results